Effects of Infertility Drug Exposure on the Risk of Borderline Ovarian Tumors: A Systematic Review and Meta-Analysis

Whether infertility drug exposure increases the risk of borderline ovarian tumors (BOTs) remains controversial. The present study was conducted with a comprehensive search for studies published from January 1990 to December 2021 in the online databases Cochrane Library, PubMed, Web of Science and EM...

Full description

Bibliographic Details
Main Authors: Manfei Si, Xiaoxiao Wang, Xueling Song, Xiaoyu Long, Jie Qiao
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/7/1835
_version_ 1797590148847763456
author Manfei Si
Xiaoxiao Wang
Xueling Song
Xiaoyu Long
Jie Qiao
author_facet Manfei Si
Xiaoxiao Wang
Xueling Song
Xiaoyu Long
Jie Qiao
author_sort Manfei Si
collection DOAJ
description Whether infertility drug exposure increases the risk of borderline ovarian tumors (BOTs) remains controversial. The present study was conducted with a comprehensive search for studies published from January 1990 to December 2021 in the online databases Cochrane Library, PubMed, Web of Science and EMBASE. We considered the first diagnosis of a BOT as the primary outcome. The odds ratio (OR) was calculated with corresponding 95% confidence intervals (CIs) for the risk of BOTs in patients who were treated with infertility drugs. Ten studies, a total of 2,779,511 women, qualified for inclusion in this meta-analysis. The pooled OR of 1.56 (95% CI: 1.09–2.22) revealed a significant positive association between infertility drugs and an increased risk for BOTs, but for specific drugs, only CC plus Gn had statistical significance. No publication bias was detected using the Egger and Begg tests (<i>p</i> > 0.05). A significant difference in BOT incidence was observed among infertile women and nulliparous women who were treated with or without infertility drugs. In conclusion, the use of infertility drugs may increase the risk of BOTs, but a dose-dependent relationship was not observed between the number of assisted reproduction technology cycles and the risk of BOTs, and infertile women who successfully became pregnant might have a reduced risk. Registration: PROSPERO, CRD42022330775.
first_indexed 2024-03-11T01:16:24Z
format Article
id doaj.art-2a76f836aa864405bbe1639b01315810
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T01:16:24Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-2a76f836aa864405bbe1639b013158102023-11-18T18:25:37ZengMDPI AGBiomedicines2227-90592023-06-01117183510.3390/biomedicines11071835Effects of Infertility Drug Exposure on the Risk of Borderline Ovarian Tumors: A Systematic Review and Meta-AnalysisManfei Si0Xiaoxiao Wang1Xueling Song2Xiaoyu Long3Jie Qiao4Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, ChinaResearch Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, ChinaCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, ChinaCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, ChinaCenter for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, ChinaWhether infertility drug exposure increases the risk of borderline ovarian tumors (BOTs) remains controversial. The present study was conducted with a comprehensive search for studies published from January 1990 to December 2021 in the online databases Cochrane Library, PubMed, Web of Science and EMBASE. We considered the first diagnosis of a BOT as the primary outcome. The odds ratio (OR) was calculated with corresponding 95% confidence intervals (CIs) for the risk of BOTs in patients who were treated with infertility drugs. Ten studies, a total of 2,779,511 women, qualified for inclusion in this meta-analysis. The pooled OR of 1.56 (95% CI: 1.09–2.22) revealed a significant positive association between infertility drugs and an increased risk for BOTs, but for specific drugs, only CC plus Gn had statistical significance. No publication bias was detected using the Egger and Begg tests (<i>p</i> > 0.05). A significant difference in BOT incidence was observed among infertile women and nulliparous women who were treated with or without infertility drugs. In conclusion, the use of infertility drugs may increase the risk of BOTs, but a dose-dependent relationship was not observed between the number of assisted reproduction technology cycles and the risk of BOTs, and infertile women who successfully became pregnant might have a reduced risk. Registration: PROSPERO, CRD42022330775.https://www.mdpi.com/2227-9059/11/7/1835assisted reproduction technologyinfertility drugsIVFborderline ovarian tumormeta-analysis
spellingShingle Manfei Si
Xiaoxiao Wang
Xueling Song
Xiaoyu Long
Jie Qiao
Effects of Infertility Drug Exposure on the Risk of Borderline Ovarian Tumors: A Systematic Review and Meta-Analysis
Biomedicines
assisted reproduction technology
infertility drugs
IVF
borderline ovarian tumor
meta-analysis
title Effects of Infertility Drug Exposure on the Risk of Borderline Ovarian Tumors: A Systematic Review and Meta-Analysis
title_full Effects of Infertility Drug Exposure on the Risk of Borderline Ovarian Tumors: A Systematic Review and Meta-Analysis
title_fullStr Effects of Infertility Drug Exposure on the Risk of Borderline Ovarian Tumors: A Systematic Review and Meta-Analysis
title_full_unstemmed Effects of Infertility Drug Exposure on the Risk of Borderline Ovarian Tumors: A Systematic Review and Meta-Analysis
title_short Effects of Infertility Drug Exposure on the Risk of Borderline Ovarian Tumors: A Systematic Review and Meta-Analysis
title_sort effects of infertility drug exposure on the risk of borderline ovarian tumors a systematic review and meta analysis
topic assisted reproduction technology
infertility drugs
IVF
borderline ovarian tumor
meta-analysis
url https://www.mdpi.com/2227-9059/11/7/1835
work_keys_str_mv AT manfeisi effectsofinfertilitydrugexposureontheriskofborderlineovariantumorsasystematicreviewandmetaanalysis
AT xiaoxiaowang effectsofinfertilitydrugexposureontheriskofborderlineovariantumorsasystematicreviewandmetaanalysis
AT xuelingsong effectsofinfertilitydrugexposureontheriskofborderlineovariantumorsasystematicreviewandmetaanalysis
AT xiaoyulong effectsofinfertilitydrugexposureontheriskofborderlineovariantumorsasystematicreviewandmetaanalysis
AT jieqiao effectsofinfertilitydrugexposureontheriskofborderlineovariantumorsasystematicreviewandmetaanalysis